Drug intelligence / Profile preview

hemerocallis citrina

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

Hemerocallis citrina, commonly known as the daylily, is a perennial herb native to East Asia that is widely utilized as both a functional food and a traditional medicinal plant. Pharmacological investigations have identified several bioactive fractions, including total flavonoids (HCFs), total phenols (HLTP), and specific coumaroylquinic acids (3-O-p-coumaroylquinic acid and 4-O-p-coumaroylquinic acid), which exhibit potent antidepressant properties. These effects are mediated through the modulation of the microbiota-gut-brain axis, inhibition of neuroinflammation (reducing IL-6 and TNF-α), and activation of the PKA/CREB/BDNF signaling pathway to enhance neurotrophic support and monoamine neurotransmitter levels (serotonin, dopamine, and norepinephrine). Additionally, the plant contains polysaccharides with antioxidant and anti-aging potential, and its aqueous extracts serve as a natural laxative by promoting small intestinal motility and increasing fecal moisture. Recent research also explores its utility in neuroprotection against amyloid-beta toxicity and as a stabilizing agent for green-synthesized nanoparticles in wound healing applications.

Other names
daylilyHemerocallis citrina BaroniDatong Huanghuacitron daylily
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on hemerocallis citrina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hemerocallis citrina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call